Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was founded in 1982 and is headquartered in Tucson, Arizona.
Search:
You do not have permission to access this chart.
Please Sign Up or Login
News for Accelerate Diagnostics, Inc. (AXDX)
minutes ago | Banggood.com
58 minutes ago | Aliexpress.com
a week ago | PRNewsWire
a week ago | PRNewsWire
2 weeks ago | The Motley Fool
2 weeks ago | Zacks Investment Research
a month ago | PRNewsWire
a month ago | The Motley Fool
a month ago | PRNewsWire
a month ago | PRNewsWire
2 months ago | PRNewsWire
3 months ago | Zacks Investment Research